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ABSTRACT
Chimerism analysis is an essential tool in the follow-up of patients after allogeneic stem cell transplantation.
High-resolution methods for chimerism analysis based on real-time quantitative polymerase chain reaction
(RQ-PCR) with a detection limit of 0.1% marker-specific cells are especially valuable in the detection of
patient-derived subpopulations for the monitoring of minimal residual disease. Using artificial chimeric
mixtures of genotypically different cells, we optimized and evaluated the intrasample variation, accuracy, and
detection limit of chimerism analysis based on RQ-PCR of short insertion and deletion polymorphisms.
Furthermore, automated setup by robot was evaluated. The results were accurate, with acceptable intrasample
variation at and above 0.1% marker-specific cells. The sensitivity was mainly limited by background values.
Chimerism results based on RQ-PCR were similar to results based on PCR of short tandem repeats when
samples from recipients of transplants with nonmyeloablative conditioning were analyzed. Furthermore,
automated setup was feasible in a time-, labor-, and reagent-conserving manner.
© 2005 American Society for Blood and Marrow Transplantation
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Allogeneic stem cell transplantation with various
onditioning regimens is a well-established treatment
odality for many hematologic diseases [1-3]. Chi-
erism analysis distinguishing donor from recipient
n hematopoietic cell subsets after allogeneic stem cell
ransplantation is routine in the follow-up of patients.
himerism analysis early after transplantation reﬂects
ngraftment kinetics, whereas analysis after engraft-
ent assists the interpretation of clinical events such
s graft-versus-host disease, secondary graft rejection,
inimal residual disease, and disease relapse. Infor-
ation about chimerism status is especially important
n the follow-up of patients undergoing allogeneic
tem cell transplantation with nonmyeloablative con-
itioning, because immunomodulatory therapeutic in-
58ervention is an essential part of the management of
hese patients [4-11].
Chimerism analysis based on polymerase chain
eaction (PCR) of polymorphisms such as variable
umber of tandem repeats or microsatellites/short
andem repeats (STR) with subsequent ﬂuorescence
etection of size-fractionated products is the standard
ethod of examination. This method is well tested
nd has a detection limit of 1% to 5% [12-16]. New
ethods based on real-time quantitative PCR (RQ-
CR) of single nucleotide polymorphisms or short
nsertion/deletion polymorphisms have the advantage
f a lower detection limit (approximately 0.1%) and
re in some cases also time saving [17-23]. Validation
nd testing of the new methods are, however, neces-
ary to conﬁrm their applicability.The purpose of this study was to optimize and
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Hematopoietic Chimerism Analysis Based on Real-Time Quantitative PCR
Bvaluate the intrasample variation, accuracy, and de-
ection limit of chimerism analysis by RQ-PCR based
n short insertion and deletion polymorphisms as pre-
iously described by Alizadeh et al [17]. In addition,
utomated setup by a robot was evaluated. The auto-
ated RQ-PCR assay was compared with chimerism
nalysis based on STR-PCR. Optimization and eval-
ation were performed on chimeric cell mixtures,
hereas comparison of RQ-PCR–based with STR-
CR–based chimerism analysis was performed on
lood samples obtained from patients who underwent
eripheral blood stem cell transplantation after non-
yeloablative conditioning.
ATERIALS AND METHODS
ample Preparation and DNA Extraction
Chimeric cell mixtures were made by serial dilu-
ions of pregenotyped leucocytes from volunteers for
esting of 17 of the 19 polymorphic genetic markers
escribed by Alizadeh et al [17]. Peripheral blood
ononuclear cells (PBMCs) were isolated by Ficoll
ensity gradient centrifugation (Lymfoprep; Axis
hield PoC, Oslo, Norway) and counted twice in a
emocytometer after staining with methyl violet. A
inimum of 300 cells were counted each time, and the
ean count was used for subsequent dilution. For 15
f the evaluated allele-speciﬁc markers, PBMCs with
he homozygous allele were diluted in PBMCs with-
ut the speciﬁc allele to obtain the following propor-
ions of chimeric cell mixtures: 0%, 0.001%, 0.01%,
.1%, 1%, 10%, 50%, 90%, and 100%. The markers
05B and S09B were tested by dilution of PBMCs
eterozygous for the speciﬁc allele in the same cell
ixtures. The 2 less informative biallelic markers
S05A and S09A) were not tested. The primers and
robe for the marker S02 were substituted during the
tudy, so that all analyses in the 384-well plates were
erformed with new primers and probe (new S02:
orward primer, AACTTTTGCCGAAGCTCACAA;
everse primer, TTGGTTTTCGCAGGCAGACT;
robe, CAGGCGCCTGAGCCACCCTCA). DNA
as extracted from each cell mixture by combined Tri-
on-X/sodium dodecyl sulfate detergent and sucrose ly-
is, proteinase K digestion, 6 mol/L NaCl2 extraction,
sopropanol precipitation, and ethanol wash [24].
For the comparison of chimerism analysis based
n STR-PCR versus RQ-PCR, peripheral blood sam-
les were obtained from 11 randomly selected recip-
ents of hematopoietic stem cell transplants after non-
yeloablative conditioning with ﬂudarabine and 2 Gy
f total body irradiation [25,26]. The leucocytes in the
lood samples taken after transplantation were sepa-
ated into speciﬁc lineages with immunomagnetic
eads (Dynabeads; Dynal, Oslo, Norway) by using
nti-CD15, anti-CD4, and anti-CD8 beads. DNA was d
B & M Txtracted as described previously. STR-PCR–based
nd RQ-PCR–based chimerism analysis was per-
ormed in parallel on 300 DNA samples. The study
as approved by the local ethics committee.
himerism Analysis Based on RQ-PCR
To minimize the background signal while attain-
ng sufﬁcient DNA ampliﬁcation, RQ-PCR condi-
ions were optimized for each speciﬁc marker by eval-
ating triplet DNA standard ampliﬁcation curves with
ﬁxed probe concentration at 200 nmol/L and either
varying annealing temperature between 60°C and
2°C or a decreasing primer concentration (600, 100,
0, and 25 nmol/L).
Intrasample variation, accuracy, and detection
imits of optimized RQ-PCR–based chimerism anal-
sis were evaluated on the chimeric cell mixtures by
se of the allele-speciﬁc marker only. To test the
ntrasample variation, triplicates of DNA extracted
rom the cell mixtures were analyzed twice for each
llele-speciﬁc marker by using 96-well plates under
he same conditions, and the mean results of the trip-
icates from the 2 analyses were compared. Accuracy
as deﬁned as the ability to obtain an RQ-PCR result
orresponding to the cell mixture. Accuracy was eval-
ated both in 96-well and 384-well plates, because the
nal reaction volumes and, thus, the target DNA con-
entrations were different in the 2 types of plates (see
CR conditions, below). The detection limit was es-
imated as the minimal cell mixture percentage detect-
ble in both 96-well and 384-well plates.
Optimized RQ-PCR analysis on patient DNA
amples was ﬁnally compared with chimerism analysis
ased on STR-PCR. All patient samples were ana-
yzed in the 384-well plates.
Optimization was performed on the ABI PRISM
700 Sequence Detection System (Applied Biosys-
ems, Foster City, CA), and cell mixtures and patient
amples were analyzed on the ABI PRISM 7900HT
equence Detection System (Applied Biosystems).
arallel analyses on the 7900HT and 7700 apparatus
howed no differences (data not shown). The baseline
oise level was always set at 20 cycles, and the thresh-
ld at Rn was 0.1, where Rn was the normalized
eporter signal minus the baseline signal.
PCR conditions were as follows: 100 ng of DNA
ixed with 15 L of Master Mix 2 Buffer (Applied
iosystems) (96-well system) or 10 L of Master Mix
 Buffer (384-well system), 100 nmol/L primer, and
00 nmol/L probe in a ﬁnal volume of 30 L (96-well
ystem) or 20 L (384-well system). PCR cycles were
minutes at 50°C followed by 10 minutes at 95°C and
0 ampliﬁcation cycles (95°C for 15 seconds and
0°C-62°C for 60 seconds).
A standard ampliﬁcation curve was made by serial
ilutions of DNA with the allele-speciﬁc marker sus-
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5ended in DNA without the speciﬁc marker in each
late in the following dilutions: 1:0, 1:10, 1:100,
:1000, 1:10 000, and 1:100 000. DNA was either
eterozygous or homozygous for the allele-speciﬁc
arker, depending on the composition of the cell
ixture or patient sample being assessed. All samples
ere correlated with the standard ampliﬁcation curve,
nd chimerism percentages were calculated by means
f SDS 2.2 software (Applied Biosystems). The chi-
erism percentage was corrected for the number of
NA copies in each sample by using a genome-equiv-
lent standard ampliﬁcation curve made by serial di-
ution of DNA in the interval of 500 to 100 000 copies
n an active reference system (the glyceraldehyde
hosphate dehydrogenase gene or the albumin gene)
17,27].
The results of all analyses in the 384-well plates
ere furthermore calculated by the comparative
ethod with the formula
QU ⁄QC (1E)(CtUCtC),
here QU is the normalized quantity of DNA se-
uences in the unknown sample, QC is the normal-
zed quantity of DNA sequences in the calibrator
ample (ie, the patient or donor pretransplantation
NA sample), Ct is the threshold cycle, Ct is
tallele-speciﬁc marker system  Ctactive reference system,
CtU is Ct in the unknown sample, and CtC is
Ct in the calibrator sample. E describes the PCR
fﬁciency, calculated by E  10(1/slope). If the efﬁ-
iency of the PCR was 100%, then the formula of the
omparative method could be reduced to [17,28-31].
QU ⁄QC 2(CtUCtC)
esults obtained by the 2 methods of calculation were
dentical (data not shown). Results obtained by the
tandard curve method were used subsequently, be-
ause it gives the opportunity to evaluate the efﬁciency
nd reproducibility of PCR cycling in each plate.
For comparison of RQ-PCR and STR-PCR, all
atient samples were analyzed in triplicate with a pa-
ient and a donor allele–speciﬁc genetic marker on the
ame 384-well plate with the RQ-PCR method. The
ean of triplicate values was used for comparison.
Background signals were deﬁned as signals derived
rom DNA without the allele-speciﬁc marker analyzed
n a given allele-speciﬁc marker system. Background
NA 100 and 300 ng without the allele-speciﬁc
arker was analyzed on all plates.
When patient samples were analyzed, the sample
urves were compared with the background curves to
heck for overlap. If the curves were overlapping, then
he signal of the patient sample could not be consid-
red as a signal of chimeric cells but was interpreted as
ossible nonspeciﬁc background noise and, thus, as a
egative signal. l
60utomation of Chimerism Analysis Based
n RQ-PCR
PCR analysis in 384-well plates was performed to
valuate an automated robot-assisted setup. Setup in
84-well plates was performed with a Biomek 2000
obot (Beckman Coulter, Fullerton, CA), which al-
owed direct transfer of premixed PCR reagents and
NA in known concentrations from patient and stan-
ard curve samples into the 384-well plate. This per-
itted simultaneous analysis of 39 samples from 1
atient in both the patient- and donor-speciﬁc genetic
arker systems, including standard ampliﬁcation
urves, background controls, and active reference sys-
ems for all samples (the robot setup design and
preadsheet are available on request). Figure 1 illus-
rates the distribution of reagents and DNA on the
84-well plate.
himerism Analysis Based on STR-PCR
Patient samples were analyzed by ﬂuorescence-
ased STR-PCR by using a combination of 7 micro-
atellite systems. The detection limit for the system as
whole was approximately 1% to 5% [14,32]. From
ach isolated patient cell linage, 100 ng of DNA was
dded to 50 L of PCR reaction containing 2 mmol/L
eoxyribonucleoside triphosphates, 200 mmol/L Tris-
Cl, 500 mmol/L KCl, 50 mmol/l MgCl2, 600 to
200 nmol/L of the primers, and 1.25 U of Taq DNA
olymerase (Platinum; Invitrogen, Carlsbad, CA), fol-
owed by ampliﬁcation on the PTC-200 Peltier Ther-
al Cycler (MJ Research, Watertown, MA) with ini-
ial DNA denaturation at 94°C for 2 minutes. Cell
ycling consisted of denaturation at 94°C for 60 sec-
nds, primer annealing at 60°C for 60 seconds, and
rimer extension at 72°C for 60 seconds for 26 cycles.
ﬁnal 10-minutes extension at 72°C followed the last
ycle.
PCR ampliﬁcation product (1-2 L) was mixed
ith formamide and standard GeneScan 350 TAMRA
Applied Biosystems), denatured at 100°C for 4 min-
tes, and immediately chilled before analysis with cap-
llary electrophoresis on an automated 310 Genetic
nalyzer by using Performance Optimised Polymer 4
Applied Biosystems). Data were analyzed by GeneS-
an software version 3.12 (Applied Biosystems).
tatistics
All chimerism results on patients, both STR and
Q-PCR based, are reported as donor percentages.
he lowest chimerism value of the 2 marker systems
as always used for determination of the chimerism
ercentage. That is, if the lowest chimerism value was
he value calculated from the patient-speciﬁc marker
ystem, then the reported chimerism percentage was
alculated by subtracting this value from 100%. If the
owest chimerism value was the value calculated from
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Hematopoietic Chimerism Analysis Based on Real-Time Quantitative PCR
Bhe donor-speciﬁc marker, then the value would be
eported directly. This method of calculation circum-
ents the problem of the increased absolute variation
f donor chimerism results seen with higher fractions
f donor DNA in the PCR reaction. This problem can
e illustrated as follows: a difference of 1 PCR cycle
orresponds to 100% variation in estimated DNA in
he sample. By using the comparative method and
onsidering, for example, a 0.5 threshold cycle error,
his will correspond to a variation in DNA of 50%.
he result of a sample with a chimerism value of 1% will
hus vary between 0.75% and 1.5%, a chimeric sample of
0% will vary between 37.5% and 75%, and a chimeric
ample of 99% will vary between 75% and 150%.
Bland and Altman statistics were used for assessing
he agreement between ﬁrst and second analyses [33].
he differences and means of ﬁrst and second analyses
ere plotted against each other to compare the results
f the 2 analyses of RQ-PCR for information on
ntrasample variation. The limits of agreement were
alculated as the mean difference between the 2 anal-
ses  2 times the standard deviation. Because the
ariation of absolute difference increases as the chi-
eric value increases, all data were log-transformed.
he same method was used to compare RQ-PCR–
ased with STR-PCR–based chimerism analysis.
The Wilcoxon matched pairs test was used to
ompare the results of the RQ-PCR–based chimerism
nalysis of the cell mixtures. Statistical analyses were
Figure 1. Theerformed with GraphPad Prism version 4 for Windows b
B & M TGraphPad Software Inc., San Diego, CA) and SAS ver-
ion 8 for Windows (SAS Institute Inc., Cary, NC).
ESULTS
ptimization of RQ-PCR Conditions
Reduction of the primer concentration to less than
00 nmol/L resulted in fading background signals for
ost genetic markers. With a reduction to less than
00 nmol/L, a clear tendency toward declining ampli-
cation was seen in most systems independently of the
nnealing temperature. Consequently, a primer con-
entration of 100 nmol/L was chosen for all systems.
ncreasing the annealing temperature from 60°C to
2°C reduced the background proportions further for
everal markers without affecting the ampliﬁcation.
n annealing temperature of either 60°C (systems 01,
2, 04, 05, 06, 07, 09, 010, and 011) or 62°C (systems
3 and 08) was chosen.
ntrasample Variation, Accuracy, and Detection
imit of Chimerism Analysis Based on RQ-PCR
Intrasample variation was examined in the 96-well
lates by 2 identical analyses on each cell mixture for
ach allele-speciﬁc genetic marker. Reproducible re-
ults were obtained from 0.1% marker-speciﬁc cells
Figure 2A). From 0.1% to 100% cell mixtures, the
imits of agreement of the log-transformed difference
ll plate setup.etween the 2 analyses were 0.22 to 0.25; ie, 95% of
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5ases of the second analyses will be between 0.60 and
.77 times the ﬁrst analyses of RQ-PCR (Figure 2B).
t less than 0.1% marker-speciﬁc cells, the variation
ncreased considerably.
Chimerism results on cell mixtures for evaluation
f accuracy and detection limits are shown in Table 1.
ccurate results were obtained with cell mixtures con-
aining 0.1% to 10% marker-speciﬁc cells, except for
.1% marker-speciﬁc cells in the 384-well plates,
here a high coefﬁcient of variation was found be-
ause of low sensitivity in a single genetic marker
ystem (system S01B [17]). If system S01B was ex-
luded from the 384-well plate, then the median value
f RQ-PCR results at 0.1% marker-speciﬁc cells was
.08% (range, 0.02%-0.21%), with a coefﬁcient of
ariation of 56%.
igure 2. A, Intrasample variation of RQ-PCR–based chimerism
nalysis on cell mixtures from 0.001% to 100% allele-speciﬁc cells
n each allele-speciﬁc marker in 2 different analyses in 96-well
lates. B, Bland-Altman plot comparing log-transformed differ-
nces and means of ﬁrst analyses and second analyses on cell mix-
ures from 0.1% to 100% allele-speciﬁc cells. On the x-axis, 2
orresponds to 0.01%, 1 to 0.1%, 0 to 1%, 1 to 10%, and 2 to
00% allele-speciﬁc cells.At less than 0.1% marker-speciﬁc cells, the varia-
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Hematopoietic Chimerism Analysis Based on Real-Time Quantitative PCR
Bion of RQ-PCR results increased considerably; ie, the
ccuracy failed. At 50% marker-speciﬁc cells, the
oefﬁcient of variation was constant or declining, but
n increased absolute variation of chimerism results
as observed, as expected.
In clinical transplantation settings, distinguishing
ixed chimerism from complete donor chimerism is
ery important in relation to minimal residual disease.
n the 96-well plates, 0.1% and 0.01% cell mixtures
ould be distinguished from 0% by RQ-PCR–based
nalysis (P  .001 and P  .001, respectively; Wil-
oxon matched pairs test). No signiﬁcant difference
ould be found between 0.001% cell dilution and 0%
P  .804). In the 384-well plates, virtually the same
ircumstances were demonstrated, as 0.1% and 0.01%
ell mixtures could be distinguished from 0% (P 
001 and P  .007, respectively). No signiﬁcant dif-
erence was found between 0.001% cell mixture and
% (P  .510). This makes sense, because the PCR
eactions contained only 100 ng of DNA in total (ie,
pproximately 16,000 DNA copies in total, leading to
n average of only 0.16 DNA copies of the speciﬁc
arker per well in the 0.001% mixture). In both the
6-well and 384-well plates, the 0.1% and 0.01% cell
ixtures could be distinguished from each other (P 
001 and P  .001, respectively).
The median value of 100 ng of background DNA
n the 96-well plates was 0.002% (range, 0%-0.145%).
hree hundred nanograms of background DNA
howed a slightly higher background value, with a
edian of 0.004% (range, 0%-0.007%). Results from
he 384-well plates showed slightly higher values, with
median at 100 ng of background DNA of 0.005%
range, 0%-0.998%) and of 0.002% (range, 0%-
.445%) at 300 ng of background DNA. Again the
ne genetic marker system (S01B) with reduced sen-
itivity in the 384-well plates increased the back-
round percentages. When the genetic marker S01B
as excluded, background analyses showed a median
alue of 0.004% (range, 0%-0.084%) at 100 ng of
ackground DNA and 0.002% (range, 0%-0.104%) at
00 ng of background DNA. Overall, especially taking
he background values into consideration, we found
hat 0.1% marker-speciﬁc cells could be accurately
nd reproducibly detected.
utomation of Chimerism Analysis Based
n RQ-PCR
The maximal number of chimerism samples that
an be analyzed in a 384-well plate with the described
etup is 39. Preparations for pipetting of 39 patient
NA samples, standard curve samples, and back-
round DNA samples together with preparation of
CR reagents of both the patient- and donor-speciﬁc
enetic marker system and the active reference system
ere performed within approximately 2 hours (exclu-
ive DNA extraction); pipetting by the robot was per- c
B & M Tormed within 1.5 hours. Analyses on the 7900HT
pparatus were performed within 2 hours, and post-
CR data analyses were performed within 1 hour. In
otal, a duration of approximately 6.5 hours was thus
sed to analyze 39 patient DNA samples. In compar-
son, it would take ten 96-well plates to analyze 39
atient DNA samples manually. Preparation of sam-
les and PCR reagents together with manual pipetting
nto one 96-well plate were performed within 1.5
ours, analyses on the 7900HT apparatus were per-
ormed within 2 hours, and post-PCR data analyses
ere performed within approximately 30 minutes.
his sums up to approximately 40 hours for the same
umber of samples in the 96-well plate setting. The
obot-assisted setup thus reduces the working time
rom 1 week to 1 day.
Apart from being time saving, analysis costs could
e reduced by using 384-well plates with robot pipet-
ing. Only 10 L of Master Mix 2 Buffer (Applied
iosystems) was applied per well in the 384-well
lates, compared with 15 L of Master Mix 2 Buffer
er well in the 96-well plates. Furthermore, fewer
ells for standard curves and controls are used per
ample in the 384-well plates compared with 96-well
lates. Master Mix 2 Buffer is one of the major
xpenses of this analysis; nearly 4 mL of Master Mix
 Buffer is required in a full 384-well plate, at a cost
f approximately 360€, whereas the equivalent 96-well
late setting would require approximately 14 mL, cor-
esponding to 1260€, or a factor of 3.5.
omparison of STR-PCR and RQ-PCR for
himerism Analysis
A high degree of correlation between chimerism
esults of patient samples obtained by STR-PCR and
Q-PCR was seen (Figure 3). Chimerism results were
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igure 3. Comparison of donor chimerism results based on STR-
CR and RQ-PCR for 300 DNA extracts from recipients of hema-
opoietic stem cell transplants with nonmyeloablative conditioning.alculated on the basis of either the patient or the
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5onor allele–speciﬁc marker, as described in the “Ma-
erials and Methods” section, and always presented in
onor chimerism. The distribution of corresponding
himerism analyses was skewed, with 34 correspond-
ng analyses with less than 25% chimerism, 62 corre-
ponding analyses with 25% to 75% chimerism, and
04 corresponding analyses with more than 75% chi-
erism because of the typical progression toward full
onor chimerism after stem cell transplantation. Anal-
ses resulting in 0% donor chimerism were excluded.
gain, Bland and Altman statistics were used to cal-
ulate agreement between the 2 methods. Limits of
greement of the log-transformed difference between
ethods were 0.11 to 0.12; ie, 95% of cases of
Q-PCR–based analyses will be between 0.78 and
.32 times the STR-PCR–based analyses (Figure 2b).
hus, the RQ-PCR–based analyses differed from the
TR-PCR–based analyses from 22% below to 32%
bove, a difference corresponding to less than 0.5
hreshold cycles between the 2 methods. This means
hat, in a chimeric sample of 1%, 95% of the RQ-
CR–based results will lie between 0.8% and 1.3%,
hereas in a chimeric sample of 50%, 95% of RQ-
CR–based results will lie between 39% and 66%. A
himeric sample of 99% has been calculated on the
asis of 1% patient chimerism (100%  1%  99%);
onsequently, the difference also has to be calculated
n this basis. That is, in a chimeric sample of 99%,
5% of RQ-PCR–based results will lie between
8.7% and 99.2%.
ISCUSSION
Determination of chimerism status is an essential
nd time-consuming analysis in the follow-up of pa-
ients after allogeneic stem cell transplantation
5-7,34,35]. It is therefore important to focus on the
ifferent methods available for analysis of this pa-
ameter. We evaluated a method based on RQ-PCR
s an alternative or supplement to an analysis based
n STR-PCR. The RQ-PCR–based method has
hown promising results, especially in regard to the
ower detection limit of this method compared with
he more established STR-PCR–based method
6,17,18,21]. The difference in sensitivity between the 2
ethods lies mainly in the smaller dynamic range of the
TR-PCR method [36]. Furthermore, less nonspeciﬁc
ackground might be expected in the RQ-PCR–based
ethod because it is based on speciﬁc primers and
robes that amplify patient and donor alleles in separate
ells, whereas patient and donor alleles are ampliﬁed in
he same tube with the same primers in the STR-PCR–
ased method [17]. The one decade lower detection
imit in RQ-PCR–based methods compared with STR-
CR–based methods is especially attractive in the deter-
ination of low patient cell fractions as indicators of d
64inimal residual disease. The correlation between per-
istent patient-derived cell subpopulations and relapse of
nderlying disease after allogeneic stem cell transplanta-
ion has most clearly been demonstrated for the malig-
ant myeloid diseases [14,37-39].
After conditions of PCR were optimized for each
f the allele-speciﬁc markers, evaluation of in-
rasample variation showed reproducible results down
o 0.1% marker-speciﬁc cells. Results in the 96-well
nd 384-well plates showed accurate values between
.1% and 10% marker-speciﬁc cells. Below 0.1%, the
ystem fails because of inaccuracy and overlapping
ackground signals. Above 50% marker-speciﬁc cells,
he system also fails because of inaccuracy, which can
e explained by the higher amount of target DNA in
he PCR reaction and, therefore, higher absolute vari-
tion. To circumvent this problem, we used the lowest
himerism value of the 2 speciﬁc marker systems in
he analysis of the patient samples to calculate the
himerism percentage. Using this method of subtrac-
ion, the accuracy of chimerism results is satisfactory
rom 0.1% to 99.9%, with the highest absolute vari-
tion in the mid interval symmetrically around 50%
himerism, but with the same relative variation in the
ntire range. STR-PCR–based methods for chimer-
sm analysis might be more accurate in the mid
nterval, because the PCR process is based on the
omparative ampliﬁcation of the same polymorphism
etween patient and donor in the same well, in con-
rast to the RQ-PCR–based method, which relies on
ifferent polymorphisms between patients and donors
n different wells.
Background signals were one of the most impor-
ant causes of restricting the detection limit, because
verlapping background and chimerism values of ap-
roximately 0.01% render the detection of these very
ow chimerism values difﬁcult. Furthermore, restric-
ion of the study setup by inaccurate cell counting and
ilution procedures in the making of chimeric cell
ixtures has to be considered. In the light of this, the
etection limit for the RQ-PCR–based chimerism
nalysis was estimated as 0.1% marker-speciﬁc cells,
hich is also demonstrated in other single nucleotide
nd short insertion and deletion polymorphism-based
ssays [6,17,18,21]. A better sensitivity can in some
ystems be accomplished by adding more DNA to the
CR reaction, but with the risk of higher background
alues and PCR inhibition, or by adding the proce-
ure of cell sorting after transplantation, sorting the
ells in different cell lineages, for example, examining
he CD34 blasts.
The sensitivity in the 384-well plates seemed
lightly inferior compared with the same chimeric cell
ixtures analyzed in the 96-well plates. This was due
o a single system (S01B) in the 384-well plates that
id not function acceptably under the optimized con-
itions in the 384-well setting. If this genetic marker
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Bs omitted, then the 96-well and 384-well plate sys-
ems function equally well. Automation of the setup in
he 384-well plates allowed analysis of chimeric sam-
les including various controls and standard curves in
oth the patient and donor allele–speciﬁc direction in
time-, labor-, and reagent-conserving manner com-
ared with the setup of the same number of samples
ither by STR-PCR or in 96-well plates. Automated
etup is most suitable in a research setting requiring
nalysis of many samples from a single patient, but
utomated setup in transplantation centers that per-
orm many analyses a week could also be rational.
In conclusion, chimerism analysis based on RQ-
CR was accurate and had acceptable intrasample
ariation above the detection limit of 0.1% marker-
peciﬁc cells. Results based on RQ-PCR were compa-
able to results based on STR-PCR from 1% chi-
eric cells. Furthermore, automated setup was
easible, accurate, and cost-effective.
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